New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
August 20, 2014
14:11 EDTTKMRTekmira lipid nanoparticle targeting Marburg virus highlighted in journal
Tekmira Pharmaceuticals announced the publication of data in a peer-reviewed scientific journal which highlights positive results in an animal model of Marburg virus infection enabled by Tekmira's lipid nanoparticle technology. Tekmira, along with its collaborators at the University of Texas Medical Branch at Galveston, USA, published data demonstrating complete protection of nonhuman primates against lethal Marburg virus-Angola hemorrhagic fever when treatment began even up to three days following infection. The study appears in the August 20 edition of the journal Science Translational Medicine. The study was designed to determine whether it is possible to protect animals against a lethal MARV-Angola infection when treatment was started at a point when animals have detectable levels of the virus in their system and already show the first clinical signs of disease.
News For TKMR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 1, 2014
09:34 EDTTKMRActive equity options trading on open
Subscribe for More Information
09:20 EDTTKMROn The Fly: Pre-market Movers
Subscribe for More Information
07:16 EDTTKMRTekmira Ebola drug could be approved in 2015, says RBC Capital
Subscribe for More Information
06:19 EDTTKMRTekmira volatility low into CDC confirms first U.S. Ebola case in Texas
Subscribe for More Information
September 30, 2014
18:51 EDTTKMRTekmira surges after hours on first confirmed U.S. Ebola case
Subscribe for More Information
18:36 EDTTKMROn The Fly: After Hours Movers
Subscribe for More Information
17:58 EDTTKMRCDC confirms first U.S. patient diagnosed with Ebola virus
Subscribe for More Information
17:39 EDTTKMRCompanies developing Ebola treatments rise after CDC confirms U.S. Ebola case
Subscribe for More Information
16:44 EDTTKMRTekmira up 12% after hours following CDC confirmation of Ebola case in U.S.
September 26, 2014
07:47 EDTTKMREMA to review BioCryst, Sarepta, Tekmira experimental Ebola medicines
Subscribe for More Information
September 25, 2014
06:41 EDTTKMRTekmira volatility flat on wide price movement
Subscribe for More Information
September 23, 2014
06:13 EDTTKMRTekmira to collaborate with international consortium researching Ebola
Subscribe for More Information
September 22, 2014
13:02 EDTTKMRTekmira surges on FDA authorization of TKM-Ebola for emergency use
Subscribe for More Information
12:57 EDTTKMRTekmira up 20% following FDA authorization of TKM-Ebola for emergency use
09:16 EDTTKMRTekmira establishes regulatory framework for emergency use of TKM-Ebola
Subscribe for More Information
September 17, 2014
15:02 EDTTKMRCongressman questions why FDA hasn't moved on Ebola drug, The Hill says
Republican Congressman Michael Burgess said he was "bewildered" as to why the FDA continues to have a hold on Tekmira's TKS-Ebloa drug, a treatment for Ebola, according to The Hill. However, Democratic Congresswoman Betty McCollum warned against using Africa as a "testing ground" for drugs that haven't been property screened, the website noted. Reference Link

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use